Ebora Virus

3 trials

Sponsors

Morioka Shinichiro

Conditions

Ebora Virus Ebora VirusPrevention of the onset of Ebola virus and Ebola hemorrhagic fever in persons exposed to Ebola patie Ebora Virus

Phase 2

Platform to Evaluate the Safety and Efficacy of Treatments for Viral Hemorrhagic Fevers sub-protocol 02: mAb114 for Ebora Virus Patients

Active, not recruitingJPRN-jRCTs031240112

Morioka ShinichiroEbora Virus Ebora Virus

Start: 2027-03-01Target: 5Updated: 2026-06-29

Platform to Evaluate the Safety and Efficacy of post-exposure prophylaxis for viral hemorrhagic fevers sub-protocol 01:Remdesivir for patients exposed to Ebora virus

RecruitingJPRN-jRCTs031240115

Morioka ShinichiroPrevention of the onset of Ebola virus and Ebola hemorrhagic fever in persons exposed to Ebola patie Ebora Virus

Start: 2024-06-01Target: 5Updated: 2026-06-29

Platform to Evaluate the Safety and Efficacy of Treatments for Viral Hemorrhagic Fevers sub-protocol 01: REGN-EB3 for Ebora Virus Patients

Active, not recruitingJPRN-jRCTs031240113

Morioka ShinichiroEbora Virus Ebora Virus

Start: 2027-03-01Target: 5Updated: 2026-06-29